People who drink lots of sugar-sweetened soda and fruit juices may be more likely to develop chronic kidney disease than those who do not, a US study suggests. Researchers examined survey data on drinkable among 3,003 African-American men and women who were 54 years old on average and did not have kidney disease. After following participants for about 8 to 10 years, found that 185 people, or 6%, developed chronic kidney disease.
All news from Nephrology
Scientists have discovered SLAMF7 , an immune receptor, called 'monocytes.' The finding was made after studying both healthy and HIV-infected patients. Yet, for certain HIV patients who experience a myriad of health issues, the researchers found that these patients' receptors do not work properly.
A walking app designed to assess and support physical activity in medical patients – is a simpler and more accessible way than many current methods – is being developed at the University of Strathclyde.
A 5-month program involving 10 home visits from healthcare professionals significantly decreased disability in low-income older adults who already had a self-reported disability, according to a randomized clinical trial published online yesterday in JAMA Internal Medicine.
Cardiovascular Diseases (CVD) lead to atherosclerosis and heart failure and are prevalent age-related illnesses in humans. In a new study, published in the renowned journal JCI, scientists from Roland Foisner's group at the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna.
Researchers have taken an important step towards making life easier for people with hearing loss. Morten Kolbek, the Ph.D. student at Aalborg University (AAU), has developed a groundbreaking algorithm that can enable hearing aid users to take a more active part in conversations in noisy environments.
A new Diabetic Medicine study reveals that couples interventions may have beneficial effects for partners of individuals with type 2 diabetes. The study was a three-arm randomized telephone intervention trial comparing outcomes of couples calls (CC), individual calls (IC), and diabetes education calls (DE). While the focus of the trial was on diabetes outcomes for the patients, the authors also assessed whether partners who participated in derived benefit.
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis by a University of Michigan team.
Bruin Biometrics, LLC (“BBI”) has been granted U.S. Food and Drug Administration (FDA) marketing authorization for the SEM Scanner, becoming the world’s first FDA-authorised device to objectively alert clinicians to specific anatomical areas of a patient’s body at increased risk for developing pressure damage.
Getting enough of the omega 3 fatty acids DHA and EPA into the brain to study their effects on conditions such as Alzheimer's and depression—which they have been shown to help—is no easy task.